Stock BAVA BAVARIAN NORDIC A/S
Add to a list
To use this feature you must be a member
Log inSign up

News Bavarian Nordic A/S

Equities

BAVA

DK0015998017

Real-time Estimate Cboe Europe
Other stock markets
 09:19:38 2024-05-06 am EDT 		5-day change 1st Jan Change
158.2 DKK +1.69% Intraday chart for Bavarian Nordic A/S +3.54% -10.88%
Apr. 30 Bavarian Nordic Books EUR65 Million Order for Smallpox Vaccine MT
Apr. 29 Bavarian Nordic A/S Receives EUR 65 Million Contract to Supply Smallpox Vaccines for EU Strategic Reserve CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bavarian Nordic Books EUR65 Million Order for Smallpox Vaccine
MT
Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve
GL
Bavarian Nordic A/S Receives EUR 65 Million Contract to Supply Smallpox Vaccines for EU Strategic Reserve
CI
Bavarian Nordic Starts US Rolling Submission Process for Chikungunya Vaccine Candidate
MT
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate
GL
Bavarian Nordic A/S Initiates Rolling Submission of Biologics License Application with FDA for Chikungunya Vaccine Candidate
CI
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS
AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
GL
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S
GL
Morris & Dickson is the First U.S. Distributor for Bavarian Nordic's JYNNEOS, the Only FDA-approved Mpox Vaccine
AQ
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GL
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
AQ
Bavarian Nordic A/S : Notice Convening Annual General Meeting
PU
Bavarian Nordic A/S – Notice Convening Annual General Meeting
GL
Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults
MT
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland
GL
Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland
CI
REPORT OF TRANSACTIONS OF SHARES AND RELATED SECURITIES OF BAVARIAN NORDIC BY PERSONS HOLDING MANAGERIAL RESPONSIBILITIES AND OR PERSONS, COMPANIES CLOSELY ASSOCIATED WITH SUCH
AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
GL
REPORT OF TRANSACTIONS OF SHARES AND RELATED SECURITIES OF BAVARIAN NORDIC BY PERSONS HOLDING MANAGERIAL RESPONSIBILITIES AND OR PERSONS, COMPANIES CLOSELY ASSOCIATED WITH SUCH
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAVA Stock
  4. News Bavarian Nordic A/S
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW